A citation-based method for searching scientific literature

Lloyd Paul Aiello, Wanjie Sun, Arup Das, Sapna Gangaputra, Szilard Kiss, Ronald Klein, Patricia A Cleary, John M Lachin, David M Nathan. N Engl J Med 2015
Times Cited: 47







List of co-cited articles
438 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
25


Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.
John M Lachin, Neil H White, Dean P Hainsworth, Wanjie Sun, Patricia A Cleary, David M Nathan. Diabetes 2015
149
21

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
19

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
John M Lachin, Saul Genuth, Patricia Cleary, Matthew D Davis, David M Nathan. N Engl J Med 2000
17


Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.
Ian H de Boer, Wanjie Sun, Patricia A Cleary, John M Lachin, Mark E Molitch, Michael W Steffes, Bernard Zinman. N Engl J Med 2011
344
17

Effects of medical therapies on retinopathy progression in type 2 diabetes.
Emily Y Chew, Walter T Ambrosius, Matthew D Davis, Ronald P Danis, Sapna Gangaputra, Craig M Greven, Larry Hubbard, Barbara A Esser, James F Lovato, Letitia H Perdue,[...]. N Engl J Med 2010
731
14

The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.
Emily Y Chew, Matthew D Davis, Ronald P Danis, James F Lovato, Letitia H Perdue, Craig Greven, Saul Genuth, David C Goff, Lawrence A Leiter, Faramarz Ismail-Beigi,[...]. Ophthalmology 2014
138
12

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Faramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, Jan Basile, Jorge Calles, Robert M Cohen, Robert Cuddihy, William C Cushman, Saul Genuth, Richard H Grimm,[...]. Lancet 2010
807
12

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
Neil H White, Wanjie Sun, Patricia A Cleary, Ronald P Danis, Matthew D Davis, Dean P Hainsworth, Larry D Hubbard, John M Lachin, David M Nathan. Arch Ophthalmol 2008
200
12

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
12


Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Lee M Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N Antoszyk, Carl W Baker, Brian B Berger, Neil M Bressler, David Browning,[...]. JAMA 2015
353
12

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
10


Diabetic retinopathy.
David A Antonetti, Ronald Klein, Thomas W Gardner. N Engl J Med 2012
908
10

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
880
10

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
942
10

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
A C Keech, P Mitchell, P A Summanen, J O'Day, T M E Davis, M S Moffitt, M-R Taskinen, R J Simes, D Tse, E Williamson,[...]. Lancet 2007
623
10

Intravitreal aflibercept for diabetic macular edema.
Jean-Fran├žois Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
428
10

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.
Ronald Klein, Michael D Knudtson, Kristine E Lee, Ronald Gangnon, Barbara E K Klein. Ophthalmology 2008
267
10

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.
Trevor J Orchard, David M Nathan, Bernard Zinman, Patricia Cleary, David Brillon, Jye-Yu C Backlund, John M Lachin. JAMA 2015
257
10



The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
832
8

Challenges in elucidating the genetics of diabetic retinopathy.
Jane Z Kuo, Tien Y Wong, Jerome I Rotter. JAMA Ophthalmol 2014
58
8


Predicting development of proliferative diabetic retinopathy.
Kristen Harris Nwanyanwu, Nidhi Talwar, Thomas W Gardner, James S Wrobel, William H Herman, Joshua D Stein. Diabetes Care 2013
54
8

Blood pressure control for diabetic retinopathy.
Diana V Do, Xue Wang, Satyanarayana S Vedula, Michael Marrone, Gina Sleilati, Barbara S Hawkins, Robert N Frank. Cochrane Database Syst Rev 2015
71
8

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
8


Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions.
David M Nathan, Margaret Bayless, Patricia Cleary, Saul Genuth, Rose Gubitosi-Klug, John M Lachin, Gayle Lorenzi, Bernard Zinman. Diabetes 2013
127
8



Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
809
8

Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).
Emily Y Chew, Walter T Ambrosius, Letitia T Howard, Craig M Greven, Samantha Johnson, Ronald P Danis, Matthew D Davis, Saul Genuth, Michael Domanski. Am J Cardiol 2007
46
8

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.
John M Lachin, Saul Genuth, David M Nathan, Bernard Zinman, Brandy N Rutledge. Diabetes 2008
281
8

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Ryan Lee, Tien Y Wong, Charumathi Sabanayagam. Eye Vis (Lond) 2015
485
8

Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.
Naji Younes, Patricia A Cleary, Michael W Steffes, Ian H de Boer, Mark E Molitch, Brandy N Rutledge, John M Lachin, William Dahms. Clin J Am Soc Nephrol 2010
32
12


Para-inflammation in the aging retina.
Heping Xu, Mei Chen, John V Forrester. Prog Retin Eye Res 2009
423
6

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.
H C Looker, S O Nyangoma, D T Cromie, J A Olson, G P Leese, S Philip, M W Black, J Doig, N Lee, A Briggs,[...]. Diabetologia 2013
46
6

Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy.
Ronald Klein, Chelsea E Myers, Kristine E Lee, Ronald Gangnon, Barbara E K Klein. Arch Ophthalmol 2012
68
6

Retinal vascular caliber as a biomarker for diabetes microvascular complications.
M Kamran Ikram, Carol Y Cheung, Mara Lorenzi, Ronald Klein, Teresa L Z Jones, Tien Yin Wong. Diabetes Care 2013
79
6


Differential association of retinal arteriolar and venular caliber with diabetes and retinopathy.
Andrew S H Tsai, Tien Yin Wong, Raghavan Lavanya, Rongli Zhang, Haslina Hamzah, E Shyong Tai, Carol Y Cheung. Diabetes Res Clin Pract 2011
41
7

Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes.
Ekaterina Alibrahim, Kim C Donaghue, Sophie Rogers, Stephen Hing, Alicia J Jenkins, Albert Chan, Tien Y Wong. Ophthalmology 2006
62
6

The worldwide epidemic of diabetic retinopathy.
Yingfeng Zheng, Mingguang He, Nathan Congdon. Indian J Ophthalmol 2012
212
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.